Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint BlockadeTomoko Aoki(Kindai University), Naoshi Nishida(Kindai University)CancersOctober 20, 202010.3390/cancers12103048Cited by 57SaveCiteExport RISWatch citationsRelated PapersThe Impact of Normal Hepatobiliary Cell Zonation Programs on the Phenotypes and Functions of Primary Liver Tumors|Liver Cancer|2024|4